TF and prostate adenocarcinoma: Using t statistics for differential expression between 500 PRAD tumours and 67 normal prostate tissue samples, we tested systematic enrichment towards overexpression in tumour for each TF’s target genes (defined as those with TSS within 1 kb of a ChIP-seq peak); these are presented in Additional file 9.